Catalyst Wire Dossier Catalyst Wire Dossier

rFVIIIFc

recombinant factor VIII Fc fusion protein · Swedish Orphan Biovitrum
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for rFVIIIFc, covering 2014-12-12 to 2021-11-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies [Phase 4]

See pricing